Medicare Part D coverage · nitroglycerin · RxCUI 207346
nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat]
Per the CMS 2026 Part D formulary file, nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] is covered by 139 Medicare Part D plans (2.8% of enrollable products), averaging Tier 2.8, with prior authorization required on 0% of covering formularies.
- 2.8%
- Plan coverage
- 139
- Plans covering
- T2.8
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat]
Per the CMS 2026 Part D formulary file, nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] (RxNorm concept RXCUI 207346, generic name nitroglycerin) appears on 4 distinct formulary files spanning 139 Medicare Part D plan offerings - 2.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.8.
Real-world access to nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,348,161 Part D beneficiaries filled nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] in 2023, with total plan-and-beneficiary spending of $46,051,750 and an average per-beneficiary annual cost of $34.16. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] today.
Coverage Details
- Formularies covering
- 4
- Plans covering
- 139
- Coverage rate
- 2.8%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 1,348,161
- Total spending
- $46,051,750
- Avg per beneficiary
- $34.16
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $34.50 | NY |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem Medicare Advantage (HMO-POS) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem Full Dual Advantage (HMO D-SNP) | Anthem Insurance Companies, Inc. | T3 | No | $0 | IN |
| Anthem I PathWays Dual Care Advantage (HMO D-SNP) | Anthem Insurance Companies, Inc. | T3 | No | $0 | IN |
| Anthem I PathWays Dual Care Advantage NFLOC (HMO D-SNP) | Anthem Insurance Companies, Inc. | T3 | No | $0 | IN |
| Wellpoint Full Dual Advantage (HMO-POS D-SNP) | Wellpoint Iowa, Inc. | T3 | No | $0 | IA |
| Wellpoint Full Dual Advantage 2 (HMO-POS D-SNP) | Wellpoint Iowa, Inc. | T3 | No | $0 | IA |
| Wellpoint Full Dual Advantage (HMO D-SNP) | Wellpoint West Virginia , Inc. | T3 | No | $0 | WV |
| Wellpoint Full Dual Advantage (HMO D-SNP) | Wellpoint Washington, Inc. | T3 | No | $0 | WA |
| Wellpoint Dual Advantage (HMO D-SNP) | Wellpoint Washington, Inc. | T3 | No | $0 | WA |
| Healthy Blue Dual Advantage (HMO D-SNP) | Community Care Health Plan OF Louisiana, Inc. | T3 | No | $0 | LA |
| Healthy Blue Dual Advantage 2 (HMO D-SNP) | Community Care Health Plan OF Louisiana, Inc. | T3 | No | $0 | LA |
| Anthem Dual Advantage (PPO D-SNP) | Anthem Insurance Companies, Inc. | T3 | No | $0 | VA |
| Wellpoint Medicare Advantage 2 (HMO-POS) | Wellpoint Texas, Inc. | T3 | No | $0 | TX |
| Wellpoint Kidney Care (HMO-POS C-SNP) | Wellpoint Texas, Inc. | T3 | No | $0 | TX |
| Wellpoint Dual Advantage 2 (HMO D-SNP) | Wellpoint Texas, Inc. | T3 | No | $0 | TX |
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] covered by Medicare Part D?
Yes, nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] is covered by 139 Medicare Part D plans (2.8% of all Part D formularies).
What tier is nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] on Medicare Part D plans?
nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] averages Tier 2.8 across Part D plans, ranging from Tier 1 to Tier 4.
Does nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] require prior authorization?
0% of Part D formularies require prior authorization for nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat]?
In 2023, total Medicare Part D spending on nitroglycerin 0.4 MG Sublingual Tablet [Nitrostat] was $46,051,750, covering 1,348,161 beneficiaries. The average spend per beneficiary was $34.16.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA